chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 5 year old male with no pertinent medical history and being treated for an ear infection who on 17Jun03 was vaccinated SC with a 0.5ml second dose of  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant medication on 17Jun03 included diphtheria toxoid/ pertussis vaccine/tetanus (manufacturer UNK). The pt had been on clarithromycin (BIAXIN) for one week prior to vaccination for an ear infection, but was considered otherwise  well at the time of vaccination. On 17Jun03 the pt developed a rash, site of  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was very red and puffy, and his face appeared puffy. The clarithromycin (BIAXIN) was stopped. The pt was seen in the physician's office on 20Jun03 at which time the pt had itching, periorbital edema, puffiness around his face, and a slightly raised red area on his shoulder where the vaccine was administered. The pt was given one dose of diphenhydramine hydrochloride (BENADRYL) at home and the physician administered a second dose of diphenhydramine hydrochloride (BENADRYL) in the office. Subsequently, the pt recovered. It was noted that the pt had no problems following first dose of  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). It was also noted that the physician felt this reaction may have been a hypersensitivity reaction but she could not really say what it was. Additional information is not expected.
Client's wife contacted RN to inform RN that she had taken client to the emergency room the evening of 2/24/21 . She reported that on that day he had "no use of his body" and was unable to really move his arms or legs on his own. She reported while in the lobby while waiting to see the doctor that he had started regaining some of the ability to move his legs and this had increased by the time he seen the physician. She stated the doctor had completed evaluation/ workup and suggested  that the client could have had reaction to Covid-19 vaccine. She stated at the time of the call that client was doing some better and did continue to appear to be improving. RN encouraged her to contact clinic with any future concerns and updates and to call 911/ return to ER as needed. She verbalized understanding.
No adverse effect by patient. This vaccine was ordered by Dr. to be given to this 6 month old infant-the MA administered the vaccine (KINRIX to be given only to children 4-6 years). Error was noted on 01/14/2019 when insurance declined to pay for vaccine. Parent contacted. Health Department was consulted.
Patient had COVID Disease 5 months after 4th dose; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Patient had COVID Disease 5 months after 4th dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 033F21A, 041L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2022, the patient experienced COVID-19 (Patient had COVID Disease 5 months after 4th dose). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. In September 2022, COVID-19 (Patient had COVID Disease 5 months after 4th dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2022, Body temperature: 101.3 101.3 F. In September 2022, SARS-CoV-2 test: Positive.         No concomitant medications were reported. Patient had symptoms fever and chills which lasted for 2 days. Doctor told patient to get Booster in Dec-2022.
Patient received Fluzone High Dose vaccine and he should have received the Fluzone Quadrivalent vaccine. No symptoms were reported.
Information has been received from two healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 11-MAY-2015 the patient was received improperly stored VARIVAX (Merck) (lot # K026385, expiration date 15-DEC-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
On 6/8/2022, I had a cough, headache, and sore throat. I took a home test for COVID, and the result was negative. On 6/9/2022, I took another home test, which yielded a positive result. The cough and headache were worse on 6/9/2022. I also had a runny nose and aching joints. My cough was so bad that my sleep was disrupted by bronchial spasms, and I had to use my albuterol inhaler. On 6/10/2022 or 6/11/2022, I began taking NyQuil for nighttime relief, and I was able to sleep well. During the day, I took Mucinex, Tylenol, and dextromethorphan, all of which eased the symptoms and provided temporary relief.  On 6/10/2022, I called my doctor's office, and I was  prescribed Paxlovid. Two or three days after beginning the Paxlovid, I started to feel a little better and was able to do some household chores. I was also able to take my dog for a walk for the first time since having COVID on the evening of 6/14/2022. I did another home test on 6/14/2022, and I got another positive result, though the pink line was just barely discernible. At the time of this writing, I still have an intermittently runny nose (which may be due at least in part to my asthma) and intermittent cough. I feel better than I did at the beginning of my illness, as I have been sleeping better. Since the beginning of the pandemic, I have taken various precautionary measures, including masking. However, about five days before I developed symptoms, I went to my granddaughter's high graduation party, which was held outdoors, and I didn't wear a mask. None of the 50 or so guests wore masks.
Patient reported high fever (>103) and disorientation for 5 hours starting around 9:00pm evening of vaccination with Bivalent and later lingering fatigue.  Patient also reported having had "strong" reaction to previous Covid-19 vaccinations.
Patient received his 1st Pfizer dose on 12/17 and 2nd dose on 1/6. He gets tested for Covid-19 weekly at the nursing home and was negative 1/4 but tested positive on 1/8. On 1/15, he was admitted to the hospital with hypoxia and fever 102. O2 sat 88% on room air, 90% on 4L O2. No cough. BP dropped to systolic 90s. He was admitted for 10 days. Did not require ICU care.
Patients left 2nd, 3rd, and 4th fingers have been numb since receiving flu shot on 10/2/07.
Case number PHEH2014US002608 is an initial spontaneous report from the pharmacist received on 05 FEB 2014. This report refers to a 16-year-old male patient. He was accidentally vaccinated with only MEN CYW-135 liquid component of MENVEO (batch number A12119) intramuscularly and did not receive Men A lyophilized conjugate. It was reported that the patient did not experience any adverse event after the maladministration. No other information was available.
Patient states since he got the first dose of Pfizer vaccine on 2/3 and the second on 2/17.  He has gained almost 20 pounds since taking the first shot. Patient states he has gained right around 20 pounds since getting the first shot of the Pfizer vaccine.  States he had some shortness of breath right after receiving the first dose of vaccine, but that has cleared.  Felt achy and stiff and sore after the second injection.   Follow up with patient on 2/20/21 F/U with caller - He was advised at ER that he had excessive fluid retention; no other issues were identified.  He was advised to increase his furosemide dose from 20mg twice daily to 40mg twice daily for 5 days.  He continues to feel tired and weak, with slight shortness of breath. Confirmed with caller that his 2 vaccinations were separated by only 14 days.
Woke up on April 13 th with severe leg cramps . Jun 23 found several blood clots in lungs and 3 cloths in legs . admitted to hospital on ^/23/2021
The patient had a sore arm after the first dose of the vaccine for about a day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The patient had a sore arm after the first dose of the vaccine for about a day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Blood pressure high.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (The patient had a sore arm after the first dose of the vaccine for about a day). At the time of the report, VACCINATION SITE PAIN (The patient had a sore arm after the first dose of the vaccine for about a day) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient had a sore arm after the first dose of the vaccine for about a day. No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-624903 (Patient Link).
Tested positive on March 3, 2022. Symptoms were sore throat, cough, and fatigue. Sore throat and fatigue lasted a few days. Cough lasted two or three weeks.
one time patient took the flu shot and got the flu; Initial information received regarding an unsolicited valid non-serious case received from a consumer (patient) from via Social media and transmitted to Sanofi on 27-Oct-2020.   This case involves an unknown age patient reported that one time patient took the flu shot and got the flu (Influenza), while patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got the flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was influenza.   No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for influenza.  Lot number was not available for this case.
Headaches still to this day; nausea; vomiting; chills; injection site pain for over a week; not feeling good; tired; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 70-years-old non pregnant female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: not reported), via an unspecified route of administration, administered in Arm Left on 04Feb2021 12:00 (at the age of 70 years-old) as dose 1, single for covid-19 immunisation. Medical history included HBP from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not experience any known allergies. Concomitant medications included amlodipine, zinc, vitamin d3, vitamins taken for an unspecified indication, start and stop date were not reported. On 04Feb2021 14:00, the patient experienced headaches still to this day, nausea, vomiting, chills, not feeling good, tired, injection site pain for over a week and the patient reported just don't feel good. The patient did not receive any treatment for the events. The outcome of the event injection site pain for over a week was recovered on 12Feb2021 while other events were not recovered.  Information about lot/batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Large local reaction, swelling, erythema from shoulder to just above elbow of left arm. DTaP, IPV given in this arm and PPD to forearm.
Information has been received from a female licensed visiting nurse who on 22-JUL-2010 was vaccinated with a 0.65ml dose of ZOSTAVAX (Merck). The nurse reported that after receiving ZOSTAVAX (Merck) on 22-JUL-2010 she experienced redness, swelling and throbbing at the injection site and also experienced headaches. The nurse reported that she had not seen her physician about this yet but did not specify if she had spoken to the office as of yet. The patient had not recovered. Additional information has been requested.
Fever; chills; headache; sore arm at injection site; dizziness; This is a spontaneous report from a Non-contactable consumer (patient). A 57-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3248), via an unspecified route of administration, administered in arm left on 10Mar2021 at 11.15 (at the age of 57-years-old), as dose 2, single for covid-19 immunization. Patient had no known allergies and no relevant medical history. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number-EL3247) via an unspecified route of administration, administered in left arm, on 17Feb2021 at 14:00 PM as a dose 1, single for covid-19 immunization at Workplace clinic. The patient concomitant medications include Rosuvastatin (20 mg 1 multiple/Day), Istalol (ophthalmic solution) in two weeks. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test for covid prior to vaccination. The patient did not receive any vaccination prior to BNT162B2. On 10Mar2021 at 9.00 PM (same day of vaccination), the patient experience fever, chills, headache, sore arm at injection site and dizziness. The patient did not receive any treatment for adverse event. The outcome of the events was recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Information has been received from a health professional concerning a 6 to 12 week old make with gastrooesophageal reflux disease who as vaccinated with a first 2 ml oral dose of Rotateq.  Concomitant therapy included "other recommended vaccines at two months of age".  Subsequently the patient experienced fussiness and crying for about 24 hours after receiving Rotateq.  Subsequently, the patient recovered.  Medical attention was not sought.  No product quality complaint was involved.  This is one of two reports from the same source.  Additional information has been requested.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 4-year-old male birth twin who on 11-NOV-2003 was vaccinated subcutaneously with a 0.5 ml dose of MMR II.  Subsequently, on 11-JUN-2007 the patient was diagnosed with Autistic Disorder.  The patient was seen by a physician for routine examinations.  At the time of this report, the patient had not recovered from the autistic disorder.  Upon internal review, autistic disorder was determined to be an other important medical event.  The patient's twin brother developed pervasive developmental disorder following vaccination with MMR II (WAES# 0804USA01520).  Additional information has been requested.
Information has been received from a registered nurse concerning a male who was vaccinated with a dose of RECOMBIVAX HB. On that same day, the patient experienced neurological symptoms. The patient contacted the nurse for medical attention. The outcome was unknown. There was no product quality complaint. This is one of two reports from the same patient. Additional information has been requested. This is in follow-up to report(s) previously submitted on 03/07/2008. Follow-up information indicated that the reporting registered nurse had no information about this patient. Additional follow-up information indicated that the reporting registered nurse was knew nothing about the event and the patient was not a patient of their office. This is one of two reports from the same patient. No further information is available.
9/8/17-evening injection site hurt and was red, morning 9/9/17 Bicep area below injection site red. Swollen and painful. Pt used ADVIL, Ice and ARNICARE gel no relief. 9/10/17 came to pharmacy recommended adding BENADRYL to ADVIL and Ice if not better for her to see doctor Monday 9/11.
30OCT95 several hrs p/vax began to have burning in rt shoulder & progressively stiff neck; seen 31OCT-no reddness @ site, guarding of rt shoulder, appearance of stiffness but inconsistent findings on exam;
My son complained of headaches for two days and had a fever of 100.9. He also had problems with his vision. He complained about seeing objects in the home bigger than what they were and then smaller.
Almost two days with fever, body ache, burning skin, lack of energy and dizziness.
Within 1 or 2 minutes after getting the vaccine I started to feel like the left side of my face was becoming flushed.  Then I felt my face, and especially my lips, tingle;  then I seemed to be having a neurological reaction--it was like the left side of my face was becoming numb.  For the rest of the day, the left side of my face felt very different from the right-side.  There was some pain around the temple.  The next day, and even through today, 5 days later, the problem has been mainly around my eye.  My eye often feels irritation when I blink and there is some muscular quivering of my lower eyelid. After speaking to my brother who is a radiologist he decided that it was unlikely to be an allergic reaction, and because the feeling of my face on the left side was reminiscent of the feeling I had a year ago when I had shingles around my left eye, he thought the reaction could very well be related to shingles.  In other words, there was a activation of a response that resembled my shingles episode.  This was bolstered by my speaking with my neighbor who also had the pfizer vaccine who said she had a very similar reaction affecting her face that lasted several days, and she,years before, had shingles on her face (as well as the shingles vaccine).
No adverse effects reported; administered a dose of PNEUMO VAX 23 which was improperly stored; This spontaneous report was received from a nurse and refers to a patient of an unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies provided. On 31-OCT-2019, the patient was administered a dose of improperly stored pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (lot # S026366 has been verified to be a valid lot number, expiration date 17-SEP-2020) (exact dose and route of administration were not reported) for prophylaxis. The vaccine underwent a temperature excursion of 1.1 Celsius degree for 10 hours. Digital Data Logger was involved. No previous temperature excursion was reported. No adverse effects were reported. The outcome was reported as supported (unspecified).
Patient fainted within a minute of getting the vaccine. She walked to her seat in the observation area. She was unware she fainted. Her BP was 123/70. She said she felt fine she had scratched her face and hit her head when she fell on the floor. 911 was called immediately. They took her out to the ambulance because her HR was low and she eventually left on her own accord
Fever, NauseaVomting, large red raised area over the injection site Narrative: minor reaction, had vomiting, diarrhea, and fever the first day. no medical treatment necessary
Increased secretions, throat swelling, extreme difficulty swallowing own secretions, took Benadryl 50 mg at home. No improvement after 45-60 minutes. Treated in ED with IV steroids and Benadryl. Symptoms resolved over 1 hour Oral steroids for 3 days at home
Right after patient received the vaccine she turned very pale and told the technician she felt light headed. She remained seated in the room and closed her eyes a couple times but never appeared to lose consciousness.  Her dad joined us in the room and confirmed she was really nervous before the vaccine.  We kept her seated for several minutes and then she said she felt sick and vomited.  After that she started to regain her color and was able to move to the waiting room.  She sat there for about 5 more minutes and then felt well enough to leave with her dad.
Pt experienced rash on nose, eye swelling, and chest pain/palpitations. Dose 1 of the vaccine was given 05/12/2021 and dose 2 on 8/3/21.
Heart went into AFIB within 21 hrs of getting  the Moderna booster shot.  Afib lasted for 38 days until I went into the Hospital and was put under to have my heart Cardioverted back into a normal rythmn.
This spontaneous has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient received vaccinations with improperly stored VARIVAX dose number 1 on 06-MAR-2008 and dose number 2 on 21-APR-2008, both from lot# 658023/0824U with expiry date of 25-MAY-2009 (dose unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review of records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Slightly elevated heart rate; Weakness; Dizziness; Headache; Dizziness; chest pain; Shortness of breath; A spontaneous report was received from a consumer concerning a 28-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, chest pain, shortness of breath/dyspnoea, headache, weakness/asthenia, slightly elevated heart rate/heart rate increased.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Feb 2021, thirty minutes after receiving the vaccine the patient experienced the event dizziness, chest pain, shortness of breath, headache. The patient visited emergency room on 8 Feb 2021 for the events.  On 9 Feb 2021, the patient experienced the event(s) weakness, slightly elevated heart rate and dizziness worsened.  Treatment details included diphenhydramine and breathing treatment.  Action taken with mRNA-1273 in response to the events was not reported.   On 9 Feb 2021, the outcome of events dizziness, chest pain, shortness of breath, headache, weakness, slightly elevated heart rate was unknown.